| Medical and Health Sciences | Lifetime | 358 | CA 16 | 99.98 |
| Psychology and Behavioral Sciences | Lifetime | 813 | CA 47 | 99.67 |
| Medical and Health Sciences | 2021-2025 | 21 | CA 1 | 99.99 |
| Psychology and Behavioral Sciences | 2021-2025 | 46 | CA 3 | 99.89 |
| Biological Sciences | 2021-2025 | 409 | CA 11 | 99.56 |
| Clinical Pharmacology | Lifetime | 16 | CA 2 | 99.91 |
| Psychiatry and Mental health | Lifetime | 34 | CA 1 | 99.90 |
| Biological Psychiatry | Lifetime | 14 | CA 1 | 99.23 |
| Clinical Psychology | Lifetime | 513 | CA 31 | 99.34 |
| Cognitive Psychology | Lifetime | 517 | CA 29 | 98.44 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 754 | CA 26 | 97.34 |
| Behavioral Neuroscience | Lifetime | 396 | CA 17 | 86.79 |
| Applied Psychology | Lifetime | 882 | CA 46 | 78.26 |
| Clinical Pharmacology | 2021-2025 | 1 | CA 1 | 99.98 |
| Psychiatry and Mental health | 2021-2025 | 11 | CA 2 | 99.90 |
| Cognitive Psychology | 2021-2025 | 26 | CA 1 | 99.50 |
| Clinical Psychology | 2021-2025 | 60 | CA 6 | 99.60 |
| Biological Psychiatry | 2021-2025 | 4 | CA 1 | 99.19 |
| Medical Physiology | 2021-2025 | 175 | CA 9 | 97.80 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 164 | CA 8 | 97.25 |
| Cognitive Neuroscience | 2021-2025 | 237 | CA 12 | 95.85 |
| Cellular and Molecular Neuroscience | 2021-2025 | 99 | CA 5 | 92.28 |
| Clinical Neurology | 2021-2025 | 257 | CA 10 | 92.72 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 604 | CA 40 | 89.88 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 626 | CA 49 | 78.70 |
| Bipolar Disorder and Treatment | Lifetime | 8 | CA 1 | 99.88 |
| Tryptophan and brain disorders | Lifetime | 14 | CA 1 | 99.86 |
| Electroconvulsive Therapy Studies | Lifetime | 4 | CA 1 | 99.75 |
| Treatment of Major Depression | Lifetime | 9 | CA 2 | 99.88 |
| Diet and metabolism studies | Lifetime | 120 | CA 4 | 99.69 |
| Adolescent and Pediatric Healthcare | Lifetime | 31 | CA 1 | 99.43 |
| COVID-19 and Mental Health | Lifetime | 69 | CA 4 | 99.13 |
| Schizophrenia research and treatment | Lifetime | 65 | CA 2 | 99.69 |
| Long-Term Effects of COVID-19 | Lifetime | 120 | CA 3 | 98.68 |
| Mental Health Research Topics | Lifetime | 83 | CA 1 | 99.46 |
| Diabetes Treatment and Management | Lifetime | 167 | CA 8 | 99.28 |
| Cardiac Health and Mental Health | Lifetime | 109 | CA 8 | 98.91 |
| Stress Responses and Cortisol | Lifetime | 204 | CA 11 | 99.06 |
| Functional Brain Connectivity Studies | Lifetime | 322 | CA 13 | 99.16 |
| Attention Deficit Hyperactivity Disorder | Lifetime | 293 | CA 9 | 97.85 |
| Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes | Lifetime | 276 | CA 21 | 98.34 |
| Electrolyte and hormonal disorders | Lifetime | 261 | CA 11 | 97.35 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 446 | CA 42 | 97.73 |
| Mental Health Treatment and Access | Lifetime | 360 | CA 18 | 98.27 |
| Eating Disorders and Behaviors | Lifetime | 502 | CA 32 | 97.08 |
| Pharmaceutical studies and practices | Lifetime | 516 | CA 36 | 96.48 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 955 | CA 53 | 96.16 |
| Pharmacology and Obesity Treatment | Lifetime | 608 | CA 32 | 93.91 |
| Suicide and Self-Harm Studies | Lifetime | 941 | CA 55 | 93.83 |
| Coordination Chemistry and Organometallics | Lifetime | 943 | CA 44 | 93.55 |
| Digital Mental Health Interventions | Lifetime | 987 | CA 38 | 90.82 |
| Cancer-related cognitive impairment studies | Lifetime | 557 | CA 35 | 89.87 |
| Restless Legs Syndrome Research | Lifetime | 392 | CA 25 | 90.94 |
| Tryptophan and brain disorders | 2021-2025 | 1 | CA 1 | 99.96 |
| Mental Health Research Topics | 2021-2025 | 3 | CA 1 | 99.91 |
| Treatment of Major Depression | 2021-2025 | 1 | CA 1 | 99.98 |
| Bipolar Disorder and Treatment | 2021-2025 | 2 | CA 1 | 99.94 |
| Electroconvulsive Therapy Studies | 2021-2025 | 1 | CA 1 | 99.90 |
| Diet and metabolism studies | 2021-2025 | 28 | CA 1 | 99.43 |
| Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes | 2021-2025 | 10 | CA 1 | 99.07 |
| Cardiac Health and Mental Health | 2021-2025 | 14 | CA 1 | 98.69 |
| COVID-19 and Mental Health | 2021-2025 | 84 | CA 2 | 98.84 |
| Functional Brain Connectivity Studies | 2021-2025 | 70 | CA 8 | 98.97 |
| Long-Term Effects of COVID-19 | 2021-2025 | 137 | CA 2 | 98.30 |
| Schizophrenia research and treatment | 2021-2025 | 36 | CA 4 | 98.94 |
| Adolescent and Pediatric Healthcare | 2021-2025 | 34 | CA 6 | 97.31 |
| Diabetes Treatment and Management | 2021-2025 | 110 | CA 6 | 98.72 |
| Neurotransmitter Receptor Influence on Behavior | 2021-2025 | 40 | CA 1 | 97.54 |
| Mental Health Treatment and Access | 2021-2025 | 115 | CA 6 | 96.99 |
| Stress Responses and Cortisol | 2021-2025 | 178 | CA 6 | 94.41 |
| Child and Adolescent Psychosocial and Emotional Development | 2021-2025 | 532 | CA 34 | 94.72 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 419 | CA 30 | 93.48 |
| Eating Disorders and Behaviors | 2021-2025 | 301 | CA 17 | 93.62 |
| Neuroscience and Neuropharmacology Research | 2021-2025 | 973 | CA 43 | 87.98 |
| Suicide and Self-Harm Studies | 2021-2025 | 483 | CA 22 | 89.70 |
| Alcoholism and Thiamine Deficiency | 2021-2025 | 51 | CA 2 | 83.54 |
| Neuropeptides and Animal Physiology | 2021-2025 | 285 | CA 7 | 84.81 |
| Psychosomatic Disorders and Their Treatments | 2021-2025 | 446 | CA 20 | 85.52 |
| Chemical synthesis and alkaloids | 2021-2025 | 197 | CA 11 | 85.96 |
| Digital Mental Health Interventions | 2021-2025 | 760 | CA 39 | 85.18 |
| Pharmacology and Obesity Treatment | 2021-2025 | 240 | CA 16 | 82.44 |
| Mental Health and Psychiatry | 2021-2025 | 332 | CA 17 | 83.83 |
| Cancer-related cognitive impairment studies | 2021-2025 | 374 | CA 15 | 80.02 |
| Psychedelics and Drug Studies | 2021-2025 | 267 | CA 13 | 83.51 |
| Apelin-related biomedical research | 2021-2025 | 109 | CA 7 | 76.75 |
| Receptor Mechanisms and Signaling | 2021-2025 | 898 | CA 13 | 79.51 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 271 | CA 5 | 75.28 |
| Pharmacological Receptor Mechanisms and Effects | 2021-2025 | 242 | CA 3 | 70.78 |
| Psychological and Temporal Perspectives Research | 2021-2025 | 487 | CA 27 | 53.75 |
| Perfectionism, Procrastination, Anxiety Studies | 2021-2025 | 961 | CA 52 | 45.77 |